Varex Imaging (VREX) Stock Price, News & Analysis

Company Overview

Varex Imaging Corporation is a global leader in the design, development and manufacture of X-ray imaging components and subsystems that serve the medical, security and industrial markets. Established in 2017 as a spin-off from Varian Medical Systems, Varex Imaging builds on decades of expertise in X-ray technology to deliver high-performance tubes, digital detectors, generator boards and software solutions that enable advanced imaging applications.

The company’s product portfolio encompasses a broad range of X-ray tubes, from compact and stationary tubes for point-of-care medical systems to high-output rotating anodes for computed tomography (CT) scanners. Its flat panel digital detectors and CMOS-based detectors offer high spatial resolution and rapid image acquisition, while its generator boards and power solutions provide the precision and reliability required for consistent imaging performance. Varex Imaging also develops specialized imaging software and calibration tools to optimize image quality and streamline equipment integration.

Headquartered in Salt Lake City, Utah, Varex Imaging operates a network of research and development, manufacturing and service facilities across North America, Europe and Asia. Key manufacturing sites include locations in Phoenix, Mexico, the Netherlands and China. This global footprint, combined with a direct sales team and distributor partnerships, enables the company to serve more than 160 countries and support customers in hospitals, diagnostic imaging centers, security screening checkpoints and industrial inspection lines.

Varex Imaging is led by President and Chief Executive Officer Robert E. Knox, whose leadership focuses on innovation, operational excellence and customer service. Supported by a seasoned executive management team and a board of directors with deep industry experience, the company continues to invest in research and development to advance X-ray imaging technologies and address evolving market needs.

Key Stats

• Today's Range: $7.73 to $7.78
• 50-Day Range: $6.88 to $8.91
• 52-Week Range: $6.76 to $16.93
• Volume: 4,860 shs
• Average Volume: 554,493 shs
• Market Capitalization: $318.06 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $22.50
• Consensus Rating: Strong Buy

Varex Imaging Stock Analysis - MarketRank™

Varex Imaging scored higher than 84% of companies evaluated by MarketBeat, and ranked 172nd out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.8 / 5
• Analyst Rating: Strong Buy

Consensus Rating

Varex Imaging has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 1 buy rating, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Varex Imaging has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 7.55%

Earnings Growth

Earnings for Varex Imaging are expected to grow by 7.55% in the coming year, from $0.53 to $0.57 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Varex Imaging is -7.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Varex Imaging is -7.50, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Varex Imaging has a P/B Ratio of 0.58. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

6.16% of the float of Varex Imaging has been sold short.

Short Interest Ratio / Days to Cover

Varex Imaging has a short interest ratio ("days to cover") of 4.5.

Change versus previous month

Short interest in Varex Imaging has recently increased by 104.20%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Varex Imaging does not currently pay a dividend.

Dividend Growth

Varex Imaging does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 4.0 / 5
• Environmental Score: -1.09

Percentage of Shares Shorted

6.16% of the float of Varex Imaging has been sold short.

Short Interest Ratio / Days to Cover

Varex Imaging has a short interest ratio ("days to cover") of 4.5.

Change versus previous month

Short interest in Varex Imaging has recently increased by 104.20%, indicating that investor sentiment is decreasing significantly.

News and Social Media

• Score: 2.1 / 5
• News Sentiment: 0.72

News Sentiment

Varex Imaging has a news sentiment score of 0.72. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.97 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for Varex Imaging this week, compared to 3 articles on an average week.

MarketBeat Follows

Only 2 people have added Varex Imaging to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 0.8 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Varex Imaging insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $20,008.00 in company stock.

Percentage Held by Insiders

Only 4.30% of the stock of Varex Imaging is held by insiders.

VREX Stock Analysis - Frequently Asked Questions

How have VREX shares performed this year?

Varex Imaging's stock was trading at $14.59 at the beginning of 2025. Since then, VREX shares have decreased by 47.0% and is now trading at $7.73.

How were Varex Imaging's earnings last quarter?

Varex Imaging (NASDAQ:VREX) issued its earnings results on Thursday, May, 8th. The company reported $0.26 earnings per share for the quarter, beating analysts' consensus estimates of $0.14 by $0.12. The firm's revenue for the quarter was up 3.3% compared to the same quarter last year.
Read the conference call transcript.

Who are Varex Imaging's major shareholders?

Varex Imaging's top institutional investors include Assenagon Asset Management S.A. (0.27%) and Wealth Enhancement Advisory Services LLC (0.03%). Insiders that own company stock include Sunny Sanyal, Shubham Maheshwari, Jay K Kunkel, Ruediger Naumann-Etienne and Kimberley E Honeysett.
View institutional ownership trends.

How do I buy shares of Varex Imaging?

Shares of VREX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Varex Imaging own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Varex Imaging investors own include NVIDIA (NVDA), Meta Platforms (META), Tesla (TSLA), Advanced Micro Devices (AMD), Visa (V), JPMorgan Chase & Co. (JPM) and Netflix (NFLX).

Company Calendar

• Last Earnings: 5/08/2025
• Today: 7/15/2025
• Next Earnings (Estimated): 7/30/2025
• Fiscal Year End: 9/30/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Electronic Equipment
• Current Symbol: NASDAQ:VREX
• CIK: 1681622
• Web: www.vareximaging.com
• Phone: (801) 972-5000
• Fax: N/A
• Employees: 2,300
• Year Founded: N/A

Price Target and Rating

• Average Price Target for Varex Imaging: $22.50
• High Price Target: $23.00
• Low Price Target: $22.00
• Potential Upside/Downside: +191.1%
• Consensus Rating: Strong Buy
• Rating Score (0-4): 3.50
• Research Coverage: 2 Analysts

Profitability

• EPS (Trailing Twelve Months): ($1.03)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 14.58
• P/E Growth: N/A
• Net Income: -$47.70 million
• Net Margins: -5.08%
• Pretax Margin: 2.01%
• Return on Equity: 4.91%
• Return on Assets: 2.16%

Debt

• Debt-to-Equity Ratio: 1.00
• Current Ratio: 4.05
• Quick Ratio: 2.36

Sales & Book Value

• Annual Sales: $827.50 million
• Price / Sales: 0.38
• Cash Flow: $1.34 per share
• Price / Cash Flow: 5.77
• Book Value: $13.43 per share
• Price / Book: 0.58

Miscellaneous

• Outstanding Shares: 41,200,000
• Free Float: 39,428,000
• Market Cap: $318.48 million
• Optionable: Optionable
• Beta: 0.70